Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Cash flows from operating activities:
Net income	$ 989	$ 456	$ 2,191	$ 1,233
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization			344	367
Provision for loan losses	110	465	347	535	$ 1,142
Amortization of premium on securities, net			215	238
Amortization of discount on subordinated notes			15	15
Gains on sales of loans held for sale			(279)	(327)
Losses on sales and writedowns of other real estate, net		380	158	380
Gains on sales of investment securities			(60)	(42)
Increase in value of life insurance contracts			(102)	(97)
Income from life insurance benefit	(12)		(642)
Stock compensation expense			114	73
Originations of loans held for sale			(13,435)	(15,383)
Proceeds from sales of loans held for sale			15,021	15,280
Changes in assets and liabilities:
Accrued income			89	(162)
Other assets			(84)	(440)
Deferred taxes, net			(203)	(175)
Accrued interest payable			(7)	27
Other liabilities			92	(177)
Net cash flows provided by operating activities			3,774	1,345
Cash flows from investing activities:
Net increase in federal funds sold			(139)	(51)
Purchases of available for sale securities			(900)	(6,696)
Sales, maturities, and calls of available for sale securities			7,193	11,276
Purchase of restricted equity securities, net			(175)	(158)
Net increase in loans			(18,142)	(15,981)
Proceeds from sales of other real estate			374	646
Death benefit from bank owned life insurance			1,316
Purchases of property and equipment			(551)	(173)
Net cash flows used in investing activities			(11,024)	(11,137)
Cash flows from financing activities:
Net increase in noninterest-bearing deposits			5,156	25,184
Net increase (decrease) in interest-bearing deposits			(1,391)	324
Net increase in FHLB borrowings			4,088	3,694
Net decrease in other borrowings			(1,283)	(17)
Distribution of equity of noncontrolling interest			(204)
Common stock cash dividends paid			(232)
Exercise of stock options			91	13
Net settlement of vested restricted stock				(17)
Net cash flows provided by financing activities			6,225	29,181
Net increase (decrease) in cash and cash equivalents			(1,025)	19,389
Cash and cash equivalents, beginning			21,714	18,229	18,229
Cash and cash equivalents, ending	$ 20,689	$ 37,618	20,689	37,618	$ 21,714
Supplemental disclosure of cash flow information:
Cash payments for interest			1,670	1,446
Cash payments for income taxes			510	786
Supplemental disclosure of noncash investing and financing activities:
Transfer from loans to other real estate owned			697
Change in unrealized gains and losses on available for sale securities			$ (981)	$ 467